Leucine supplementation combined with resistance exercise improves the plasma lipid profile of dexamethasone-treated rats by Nicastro, Humberto et al.
SHORT REPORT Open Access
Leucine supplementation combined with
resistance exercise improves the plasma lipid
profile of dexamethasone-treated rats
Humberto Nicastro
*, Claudia R da Luz, Daniela FS Chaves, William das Neves, Kerolyn S Valente and
Antonio H Lancha Jr
Abstract
The impact of leucine supplementation and resistance exercise (RE) on plasma lipid profile was evaluated in adult
rats treated with dexamethasone, an experimental model of dyslipidemia. Total cholesterol did not differ among
groups. Furthermore, leucine supplementation did not promote improvement in the plasma total cholesterol and
LDL-c of the animals. However, plasma TG and VLDL-c were significantly decreased and HDL-c increased after 7
days of leucine supplementation combined with RE. In conclusion, leucine supplementation combined with RE, but
not isolated, improved the plasma lipid profile of dexamethasone-induced dyslipidemic rats.
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Introduction
Glucocorticoids are widely prescribed drugs in clinical
practice (chronic rheumatic diseases) due to their potent
anti-inflammatory effects. However, low dose/long term
or high dose/short term use are known to induce severe
adverse metabolic effects, such as dyslipidemia due to
elevated serum cortisol levels [1].
In contrast, leucine supplementation has demonstrated
potential therapeutic effects preventing obesity and sig-
nificantly modulating lipid profile in animals exposed to
high-fat feeding [2,3]. Corroborating such therapeutic
effects, mechanical stimuli promoted by resistance exer-
cise (RE) has also been considered a potent non-pharma-
cological tool. Muscle contraction may enhance blood
glucose uptake by skeletal muscle through insulin-inde-
pendent mechanisms [4] and improve serum lipid profile
of dyslipidemic women [5].
We aimed to evaluate the effects of two therapeutic
strategies on dexamethasone-induced dyslipidemia in
r a t s :l e u c i n es u p p l e m e n t a t i o na n dR E .T oo u rk n o w l -
edge, this is the first report evaluating the effects of
such combined interventions on dexamethasone-treated
rats.
Materials and methods
Animal’s care, dexamethasone treatment, nutritional
supplementation, and the RE protocol have been pre-
viously described [6,7]. All methods used were
approved by the Local Ethical Committee for Animal
Research.
Briefly, Wistar male rats (400-450 g) were housed
under controlled environmental conditions with free
access to food and water before the experiments were
performed. Rats were randomly divided into the follow-
ing groups: 1) dexamethasone (DEX; n = 06), 2) control
pair-fed (CON-PF; n = 06), 3), 4) dexamethasone plus
leucine (DEX-LEU; n = 07), dexamethasone plus RE
(DEX-RE; n = 05) and dexamethasone plus leucine and
RE (DEX-LEU-RE; n = 05). During 7 days, dexametha-
sone (5 mg·kg·day
-2) was given daily via drinking water.
Leucine-supplemented groups received 0.135 g·kg·day
-2
through gavage (at 09:00 a.m.). Trained rats performed 3
sessions of a squat-type exercise in one daily session with
2 days of rest interval between sessions [7]. All groups
were pair-fed to the DEX-treated group according to
individual body weight. Animals were killed by decapita-
tion after an overnight fast of 12 hours.
Plasma lipoproteins concentration (total cholesterol,
triglycerides - TG, low-density lipoprotein - LDL-c,
high-density lipoprotein - HDL-c) were measured using
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®, São Paulo, Brazil). Very
low-density lipoprotein (VLDL-c) was calculated using
Friedewald’s equation as follows: VLDL-c = TG/5.
The results are expressed as mean ± SEM. The
dependent variables were tested by analysis of variance
(ANOVA) one-way (treatment) and a post hoc test
Figure 1 Plasma lipid profile of dexamethasone-treated rats submitted to leucine supplementation and RE.H D L - c ,h i g h - d e n s i t y
lipoprotein; LDL-c low-density lipoprotein; TG, triglycerides; VLDL-c, very low-density lipoprotein. Data are expressed as mean ± SEM.
a p < 0.05
vs. CON-PF;
b p < 0.001 vs. CON-PF;
c p < 0.01 vs. DEX-LEU;
d p < 0.01 vs. CON-PF;
e p < 0.05 vs. DEX-LEU.
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comparison purposes. The significance level was set at
p < 0.05.
Results and Discussion
Figure 1 shows the plasma lipid profile of the experi-
mental groups. We observed that plasma total choles-
terol and LDL-c did not differ among groups (p > 0.05),
suggesting that, in our experimental model, dexametha-
sone-induced imbalance in plasma lipid profile did not
reflect in total cholesterol and LDL-c and that leucine
supplementation and RE were not able to modulate it.
Although not significant, DEX group presented ~24% of
increase in plasma total cholesterol compared to the
CON-PF group.
In contrast, plasma TG and VLDL-c were significantly
increased in DEX group when compared to the CON-PF
group (p < 0.05). Leucine supplementation did not worse
these plasma lipoproteins when compared to the DEX
group (p > 0.05), but increased them to a greater extent
than DEX group when compared to the CON-PF group
(p < 0.001). These data demonstrate that leucine supple-
mentation may act as a dexamethasone synergist in
induction of dyslipidemia. However, DEX-LEU-RE group
showed significantly reduced plasma TG and VLDL-c
when compared to the DEX-LEU group (p < 0.01). Since
the DEX-RE group presented no significant effect in
plasma TG and VLDL-c when compared to the DEX
group (p > 0.05), it is possible to suggest that leucine sup-
plementation and RE present therapeutic effects on dexa-
methasone-induced dyslipidemia only when they are
applied together. According to the data presented, it is
possible to speculate that leucine supplementation
enhances the effect of muscle contraction.
Corroborating these therapeutic effects, plasma HDL-c
was also significantly increased in DEX-LEU-RE group
when compared to the DEX-LEU group (p < 0.05). It is
interesting to note that DEX-RE and DEX-LEU-RE
groups showed increased plasma HDL-c in comparison
t ot h eC O N - P F - g r o u p( p<0 . 0 1a n dp<0 . 0 5 ,r e s p e c -
tively). Such data provide us two main conclusions: 1)
leucine supplementation combined with RE is definitely a
therapeutic nutritional strategy in attenuating dexa-
methasone-induced dyslipidemia and 2) even in the pre-
sence of dexamethasone, RE improved plasma HDL-c
when compared to basal condition.
In conclusion, leucine supplementation combined with
RE, but not isolated, promoted significant improvements
in the plasma lipid profile of dexamethasone-induced
dyslipidemia in rats. Such strategy can represent an
interesting nutritional strategy able to promote cardio-
vascular benefits [8].
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